✦ LIBER ✦

Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer

✍ Scribed by Ramila Philip; Elisa Brunette; Bryan Clary; Lydia Kilinski; Deepa Murugesh; Martin Sorich; Josephine Yau; Jane Lebkowski; H. Kim Lyerly; Mohan Philip

Book ID: 116167826
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 123 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)99937-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of the mage gene family in pr

Expression of the mage gene family in primary and metastatic human breast cancer: Implications for tumor antigen-specific immunotherapy

✍ Vincenzo Russo; Catia Traversari; Alessandro Verrecchia; Marcella Mottolese; Pie 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 956 KB

## Abstract Some human tumors express known antigens that can be utilized as targets for specific immunotherapy. An absolute requirement for the efficacy of this therapeutic strategy is an adequate expression of the candidate antigen by all cells of the primary and metastatic tumor. To examine the

Inhibition of constitutively active Stat

Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells

✍ Burke, William M; Jin, Xiaohong; Lin, Huey-Jen; Huang, Melinda; Liu, Rebecca; Re 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 313 KB

Modification of tumor cells with fas (CD

Modification of tumor cells with fas (CD95) antigen gene and fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer

✍ Motomu Shimizu; Takayuki Yoshimoto; Akio Matsuzawa; Yasutaka Takeda 📂 Article 📅 2003 🏛 Humana Press Inc 🌐 English ⚖ 194 KB

Alteration of the MT1 melatonin receptor

Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

✍ Ling Lai; Lin Yuan; Qi Cheng; Chunmin Dong; Lulu Mao; Steven Marc Hill 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 430 KB

Location of BRCA1 in Human Breast and Ov

Location of BRCA1 in Human Breast and Ovarian Cancer Cells

✍ Scully, R.; Ganesan, S.; Brown, M.; De Caprio, J. A.; Cannistra, S. A.; Feunteun 📂 Article 📅 1996 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 897 KB

Tumor–antigen heterogeneity of dissemina

Tumor–antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease

✍ Stephan Braun; Florian Hepp; Harald L. Sommer; Klaus Pantel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 1 views

Single micrometastatic tumor cells encased in mesenchymal tissues, such as bone marrow (BM), are regarded as suitable targets for adjuvant immunotherapy since they are easily accessible for both immunoglobulins and immune effector cells. However, the antigen profile of such cells, to which antibody